RxDoctor Payments DataLook up a doctor →

Sarah Brendle

Physician Assistant · Anderson, SCNPI 1356767735

Payments from drug & device makers

$19,330in general payments, 2019–2025

Across 870 payments — averaging $22.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$3K
  • Johnson & Johnson$1K
  • AstraZeneca$1K
  • Incyte Corporation$832
  • Merck$737
  • Pfizer$731
  • plus $12K from 54 others

What the payments were for

  • Food & beverage$16,93688%
  • Education$1,1806%
  • Other$1,2146%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis76$2,577
Johnson & Johnson57$1,438
AstraZeneca(2 entities)53$1,156
Incyte Corporation42$832
Merck36$737
Pfizer37$731
Seagen Inc.31$727
Daiichi Sankyo Inc.33$705
Eisai Inc.38$705
Bristol Myers Squibb31$595
Astellas Pharma US Inc23$567
Bayer21$541
Gilead(2 entities)16$432
Amgen21$427
Exelixis Inc.22$427
E.r. Squibb & Sons, L.L.C.26$406
Lilly USA, LLC22$399
Sanofi12$359
Regeneron Healthcare Solutions, Inc.10$343
Takeda Pharmaceuticals U.S.A., Inc.13$323
AbbVie14$310
G1 Therapeutics, Inc.8$272
Kyowa Kirin, Inc.12$268
Beigene USA, Inc.16$248
Genentech USA, Inc.12$247
GSK11$178
Pharmacosmos Therapeutics Inc.10$175
Ipsen Biopharmaceuticals, Inc8$164
Alnylam Pharmaceuticals Inc.8$159
EMD Serono, Inc.9$148
Rigel Pharmaceuticals, Inc.8$144
AVEO Pharmaceuticals, Inc.7$140
Acrotech Biopharma Inc.7$138
Boehringer Ingelheim6$132
Adaptive Biotechnologies Corporation6$127
Taiho Oncology, Inc.6$127
Jazz Pharmaceuticals Inc.7$121
Stemline Therapeutics Inc.4$103
Coherus Oncology, Inc.6$102
Pharmaessentia USA Corporation5$98
Tersera Therapeutics LLC5$95
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC4$92
Array Biopharma Inc6$92
Karyopharm Therapeutics Inc.5$81
Deciphera Pharmaceuticals Inc.4$80
Beone Medicines USA, Inc.4$74
ADC Therapeutics America, Inc.4$74
Mirati Therapeutics, Inc.3$69
Servier Pharmaceuticals LLC3$62
Genmab U.S., Inc.3$62
Sobi, Inc3$50
Puma Biotechnology, Inc.3$50
Dendreon Pharmaceuticals LLC1$49
Caris MPI, Inc.2$48
Myovant Sciences Inc.2$42
Blueprint Medicines Corporation2$39
Azurity Pharmaceuticals, Inc.2$39
Agios Pharmaceuticals, Inc.2$38
Springworks Therapeutics, Inc.2$36
Spectrum Pharmaceuticals Inc.2$34

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$19,330 in reported general payments places this provider in the 95th percentile of 1,852 physician assistant providers in South Carolina.

See all physician assistant providers in South Carolina

Most prescribed under Part D

DrugClaimsCost to plans & patients
IbrancePalbociclib11$170,456
Abiraterone Acetate12$25,735
Oxycodone Hcl102$3,345
Fentanyl23$2,123
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen79$2,035
Anastrozole74$1,451
Ondansetron Hcl80$619
Megestrol Acetate14$587
Levothyroxine Sodium33$436
Hydroxyurea13$430
Gabapentin17$383
Tramadol Hcl50$221
Lorazepam35$219
Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine26$210
Butalbital-Acetaminophen-CaffeButalb/Acetaminophen/Caffeine20$208

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerIbrance$731$170,45611 claims
Lilly USA, LLCOlanzapine$399$7613 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,852 physician assistant providers in South Carolina.

Other physician assistant in Anderson

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →